How many shares of LCTX does UBS Group AG own?

As of 2026-Q2, UBS Group AG holds 687,051 shares of LCTX (LINEAGE CELL THERAPEUTICS IN).

What is UBS Group AG's LCTX position worth?

As of 2026-Q2, UBS Group AG's LCTX position is worth $900,036.

In 2026-Q2, UBS Group AG decreased their LCTX position (-49.9% change in shares).

Based on available 13F filings, UBS Group AG first reported a position in LCTX in 2019-Q3. They have held the position across 28 quarters.

Position history for UBS Group AG's holdings in LINEAGE CELL THERAPEUTICS IN

Current Value

$900,036

Current Shares

687,051

Total Value Change

+$818,036

Total Shares Change

+603,478

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	687,051	-49.9%	$900,036	0.0%	$1.31	0
2026-Q1	Increased	1.4M	+648.4%	$2.2M	0.0%	$1.89	42
2025-Q4	Decreased	183,127	-12.0%	$305,823	0.0%	$1.60	0
2025-Q3	Decreased	208,080	-8.6%	$351,656	0.0%	$1.79	0
2025-Q2	Decreased	227,600	-13.8%	$206,433	0.0%	$0.94	0
2025-Q1	Increased	263,917	+19.5%	$119,291	0.0%	$0.49	18
2024-Q4	Increased	220,888	+28.9%	$110,886	0.0%	$0.50	19
2024-Q3	Increased	171,431	+124.2%	$155,145	0.0%	$0.92	25
2024-Q2	Decreased	76,466	-45.4%	$76,237	0.0%	$1.00	0
2024-Q1	Decreased	140,072	-3.1%	$207,306	0.0%	$1.48	0
2023-Q4	Increased	144,527	+172.8%	$157,534	0.0%	$1.09	25
2023-Q3	Decreased	52,971	-13.2%	$62,506	0.0%	$1.18	0
2023-Q2	Increased	61,037	+1776.3%	$86,063	0.0%	$1.40	24
2023-Q1	Decreased	3,253	-69.0%	$4,880	0.0%	$1.43	0
2022-Q4	Increased	10,506	+706.9%	$12,291	0.0%	$1.17	19
2022-Q3	Decreased	1,302	-88.6%	$1,000	0.0%	$1.15	0
2022-Q2	Increased	11,420	+1177.4%	$18,000	0.0%	$1.61	20
2022-Q1	Decreased	894	-97.8%	$1,000	0.0%	$1.50	0
2021-Q4	Decreased	39,932	-80.8%	$97,000	0.0%	$2.50	0
2021-Q3	Increased	207,702	+4468.9%	$523,000	0.0%	$2.54	39
2021-Q2	Decreased	4,546	-38.0%	$13,000	0.0%	$2.93	0
2021-Q1	Decreased	7,337	-70.2%	$17,000	0.0%	$2.26	0
2020-Q4	Increased	24,602	+2098.6%	$44,000	0.0%	$1.74	22
2020-Q3	Decreased	1,119	-17.5%	$1,000	0.0%	$0.94	0
2020-Q2	Decreased	1,357	-98.1%	$1,000	0.0%	$0.92	0
2020-Q1	Decreased	70,916	-54.5%	$59,000	0.0%	$0.83	0
2019-Q4	Increased	155,913	+86.6%	$139,000	0.0%	$0.86	24
2019-Q3	New	83,573	-	$82,000	0.0%	$0.96	33